Pre-market
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Calculated transaction value
$0

Stewart Jeffrey Ryan EVP, Chief Commercial Officer

ABBV
Transaction date Nov 9, 2026
Public filing date Nov 12, 2026
Filing lag Filed 3 days later

ABBV daily price context

Close on/before transaction
$293.3 Nov 9, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Option (Right to Buy) on Common Stock
Quantity / price
24,549 shares @ $0
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001761675-26-000007
Filing cohort

Transactions in this filing

Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$16.06M
Buys / sales
0 / 1
Transactions reported in the same official filing
Issuer Transaction Traded Value
Abbvie Inc. ABBV Gift Nov 12, 2026 $0
Abbvie Inc. ABBV Exercise Nov 9, 2026 $0
Abbvie Inc. ABBV Current Exercise Nov 9, 2026 $0
Abbvie Inc. ABBV Exercise Nov 9, 2026 $1.84M
Abbvie Inc. ABBV Exercise Nov 9, 2026 $2.3M
Abbvie Inc. ABBV Sale Nov 9, 2026 $11.93M